论文部分内容阅读
目的:探究甲泼尼龙对于治疗重症哮喘的临床效果。方法:选取本院收治入院的重症哮喘患者60例作为本次研究的对象,按照随机分组的原则将其分成观察组和对照组,对比分析两组患者的临床治疗效果,综合评价甲泼尼龙对于治疗重症哮喘的临床价值。结果:观察组患者的临床治疗总有效率明显较对照组高(93.33%vs 73.33%);此差异具有显著性,两组患者的PaO2、PaCO2的比较差异具有显著性,(P<0.05)具有统计学意义。结论:甲泼尼龙用于治疗重症哮喘具有显著的临床疗效,值得的临床应用。
Objective: To investigate the clinical effect of methylprednisolone in the treatment of severe asthma. Methods: Sixty patients with severe asthma admitted to our hospital were selected as the subjects of this study. They were divided into observation group and control group according to the principle of randomization. The clinical effects of two groups of patients were compared and analyzed. Clinical value of treatment of severe asthma. Results: The total effective rate of clinical observation in the observation group was significantly higher than that in the control group (93.33% vs 73.33%). There was significant difference between the two groups (PaO2 and PaCO2, P <0.05) Statistical significance. Conclusion: Methylprednisolone has significant clinical efficacy in the treatment of severe asthma and is worthy of clinical application.